T
BPTH

Thomaspartners’s Bio-Path Holdings Inc BPTH Stock Holding History

Thomaspartners’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3
Closed -$31K – 149
2014
Q2 		$31K Buy
+3
New +$32.9K ﹤0.01% 139

Other funds holding BPTH

UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Thomaspartners's BPTH Position: Q3 2014 in Review

Thomaspartners sold out of Bio-Path Holdings Inc (BPTH) in Q3 2014, closing a stake of 3 shares — an estimated $31K sold.

Thomaspartners first reported a position in BPTH in Q2 2014 and held it in 1 quarter. The position peaked at $31K in Q2 2014. 38 funds tracked by Wall St. Rank hold BPTH as of Q3 2014.

  • Thomaspartners reported no remaining Bio-Path Holdings Inc position as of Q3 2014 after selling out during the quarter.
  • Thomaspartners sold 3 Bio-Path Holdings Inc shares in Q3 2014, an estimated $31K.
  • Thomaspartners first reported a position in Bio-Path Holdings Inc in Q2 2014 and held it in 1 quarter.
  • Thomaspartners's Bio-Path Holdings Inc position peaked at $31K in Q2 2014.
  • 38 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q3 2014.

Based on Thomaspartners's 13F filing for Q3 2014, filed 10 Nov 2014.